Ondansetron treatment in Tourette's disorder: A 3-week, randomized, double-blind, placebo-controlled study

Paz Toren*, Abraham Weizman, Sharon Ratner, Donald Cohen, Nathaniel Laor

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Ondansetron treatment in Tourette's disorder: A 3-week, randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Neuroscience

Psychology